[Federal Register Volume 79, Number 162 (Thursday, August 21, 2014)]
[Notices]
[Pages 49519-49520]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-19827]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-14-0913]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    The Centers for Disease Control and Prevention (CDC), as part of 
its continuing effort to reduce public burden, invites the general 
public and other Federal agencies to take this opportunity to comment 
on proposed and/or continuing information collections, as required by 
the Paperwork Reduction Act of 1995. To request more information on the 
below proposed project or to obtain a copy of the information 
collection plan and instruments, call 404-639-7570 or send comments to 
Leroy A. Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or 
send an email to [email protected].
    Comments submitted in response to this notice will be summarized 
and/or included in the request for Office of Management and Budget 
(OMB) approval. Comments are invited on: (a) Whether the proposed 
collection of information is necessary for the proper performance of 
the functions of the agency, including whether the information shall 
have practical utility; (b) the accuracy of the agency's estimate of 
the burden of the proposed collection of information; (c) ways to 
enhance the quality, utility, and clarity of the information to be 
collected;(d) ways to minimize the burden of the collection of 
information on respondents, including through the use of automated 
collection techniques or other forms of information technology; and (e) 
estimates of capital or start-up costs and costs of operation, 
maintenance, and purchase of services to provide information. Burden 
means the total time, effort, or financial resources expended by 
persons to generate, maintain, retain, disclose or provide information 
to or for a Federal agency. This includes the time needed to review 
instructions; to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and maintaining information, and disclosing and 
providing information; to train personnel and to be able to respond to 
a collection of information, to search data sources, to complete and 
review the collection of information; and to transmit or otherwise 
disclose the information. Written comments should be received within 60 
days of this notice.

Proposed Project

    Evaluating Locally-Developed HIV Prevention Interventions for 
African-American MSM in Los Angeles (OMB Control No. 0920-0913, expires 
01/15/2015)--Extension -- National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    Data on HIV cases reported in 33 U.S. states with HIV reporting 
indicate the burden of HIV/AIDS is most concentrated in the African-
American population compared to other racial/ethnic groups. Of the 
49,704 African-American males diagnosed with HIV between 2001 and 2004, 
54% of these cases were among men who have sex with men (MSM). In Los 
Angeles County (LAC), the proportion of HIV/AIDS cases among African-
American males attributable to male-to-male sexual transmission is even 
greater (75%).
    In the absence of an effective vaccine, behavioral interventions 
represent one of the few methods for reducing high HIV incidence among 
African American MSM (AAMSM). Unfortunately, in the third decade of the 
epidemic, very few of the available HIV-prevention interventions for 
African-American populations have been designed specifically for MSM. 
In fact, until very recently, none of CDC's evidence-based HIV-
prevention interventions had been specifically tested for efficacy in 
reducing HIV transmission among MSM of color. Given the conspicuous 
absence of (1) evidence-based HIV interventions and (2) outcome 
evaluations of existing AAMSM interventions, our collaborative team 
intends to address a glaring research gap by implementing a best-
practices model of comprehensive program evaluation.
    The purpose of this project is to test, in a real-world setting, 
the efficacy of an HIV transmission prevention intervention for 
reducing sexual risk among African-American men who have sex with men 
in Los Angeles County. The intervention is a three-session, group-level 
intervention that will provide participants with the information, 
motivation, and skills necessary to reduce their risk of transmitting 
or acquiring HIV.
    The intervention is being evaluated using baseline, 3-month and 6-
month follow up assessments. This project also intends to conduct in-
depth qualitative interviews with a total of 36 men in order to assess 
the experiences with the intervention, elicit recommendations for 
improving the intervention, and to better understand the factors that 
place young African American MSM at risk for HIV.
    CDC is requesting approval for a 1-year clearance to complete data 
collection. The data collection system involves screenings, limited 
locator information, contact information, baseline questionnaire, 
client satisfaction surveys, 3-month follow-up questionnaire, 6-month 
follow-up questionnaire, and case study interviews.
    An estimated 160 men will be screened for eligibility in order to 
enroll 80 additional men to reach the desired

[[Page 49520]]

sample size of 528. The baseline and follow up questionnaires contain 
questions about participants' socio-demographic information, health and 
healthcare, sexual activity, substance use, and other psychosocial 
issues.
    There is no cost to participants other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                      Number      Average burden   Total annual
      Type of respondent            Form name        Number of     responses per  per respondent    burden (in
                                                    respondents     respondent      (in hours)        hours)
----------------------------------------------------------------------------------------------------------------
Prospective Participant.......  Outreach                     160               1            5/60              13
                                 Recruitment
                                 Assessment
                                 (screener).
Prospective Participant.......  Limited Locator              160               1            5/60              13
                                 Form.
Enrolled Participant..........  RCT Informed                  80               1           10/60              13
                                 Consent Form.
Enrolled Participant..........  Participant                   80               1           10/60              13
                                 Contact
                                 Information
                                 Form.
Enrolled Participant..........  Baseline                      80               1               1              80
                                 Questionnaire.
Enrolled Participant..........  Client                        40               3            5/60              10
                                 Satisfaction
                                 Survey.
Enrolled Participant..........  3-month follow               100               1               1             100
                                 up
                                 Questionnaire.
Enrolled Participant..........  6-month follow               170               1               1             170
                                 up
                                 Questionnaire.
Enrolled Participant..........  Success Case                  10               1           10/60               2
                                 Study Informed
                                 Consent Form.
Enrolled Participant..........  Success Case                  10               1             1.5              15
                                 Study Interview.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             429
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-19827 Filed 8-20-14; 8:45 am]
BILLING CODE 4163-18-P